Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Revelation Biosciences, Inc. (REVB) Debt to Capital Ratio data is not available.
| Income Statement Financials | |
-- |
|
$-2.05M |
|
-- |
|
-- |
|
$2.10M |
|
$-2.10M |
|
$0.04M |
|
$-2.05M |
|
$-2.05M |
|
$-2.05M |
|
$-2.05M |
|
$-2.05M |
|
$-2.05M |
|
$-2.10M |
|
$-2.09M |
|
0.97M |
|
0.97M |
|
$-2.11 |
|
$-2.11 |
|
| Balance Sheet Financials | |
$3.93M |
|
$0.04M |
|
$0.04M |
|
$3.97M |
|
$1.09M |
|
-- |
|
-- |
|
$1.09M |
|
$2.88M |
|
$2.88M |
|
$2.88M |
|
0.96M |
|
| Cash Flow Statement Financials | |
$-2.79M |
|
-- |
|
-- |
|
$6.50M |
|
$3.70M |
|
$-2.79M |
|
$0.22M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.61 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.79M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-71.20% |
|
-71.20% |
|
-51.66% |
|
-71.20% |
|
$2.99 |
|
$-2.88 |
|
$-2.88 |
|